Skip to contentR
Repligen Corp
R
RGENRepligen Corp Q2 2025 · 10-Q
Revenue$182.37M$182.37M+14.8% vs Q2 2024 Net Income$14.87M$14.87M+160.2% vs Q2 2024 EPS Diluted$0.26$0.26+160.0% vs Q2 2024 Operating Income$13,896,000+154.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$21,508,000−42.5% Margins · derivedOperating margin7.6%+4.2 pt vs Q2 2024
Net margin8.2%+4.6 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end